Muhammad M. Alhussein

Calgary, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Association Between Electrocardiographic Changes and Myocardial Injury or Death After Cardiac Surgery.

Association Between Electrocardiographic Changes and Myocardial Injury or Death After Cardiac Surgery.

Journal: The Canadian journal of cardiology

Published: April 24, 2025

Four-dimensional Cardiac Modelling of Multiphase Computed Tomography for Predicting Outcomes After Transcatheter Aortic Valve Replacement.

Four-dimensional Cardiac Modelling of Multiphase Computed Tomography for Predicting Outcomes After Transcatheter Aortic Valve Replacement.

Journal: The Canadian journal of cardiology

Published: July 21, 2024

Heterogeneity of coronary vascular function and myocardial oxygenation in women with angina and non-obstructive coronary artery disease.

Heterogeneity of coronary vascular function and myocardial oxygenation in women with angina and non-obstructive coronary artery disease.

Journal: European heart journal. Cardiovascular Imaging

Published: December 06, 2023

Predictors of persistent symptoms after mRNA SARS-CoV-2 vaccine-related myocarditis (myovacc registry).

Predictors of persistent symptoms after mRNA SARS-CoV-2 vaccine-related myocarditis (myovacc registry).

Journal: Frontiers in cardiovascular medicine

Published: April 11, 2023

Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis.

Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis.

Journal: CJC open

Published: April 15, 2021

Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity: A Phase I Trial.

Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity: A Phase I Trial.

Journal: JACC. CardioOncology

Published: April 08, 2019

Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?

Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?

Journal: The oncologist

Published: March 19, 2019

Reversible Cabozantinib-Induced Cardiomyopathy.

Reversible Cabozantinib-Induced Cardiomyopathy.

Journal: The Canadian journal of cardiology

Published: October 15, 2018

Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area.

Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area.

Journal: The Canadian journal of cardiology

Published: January 20, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026